Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Date:11/3/2009

Investment Income

Investment income was $1.0 million for the third quarter 2009 compared to $2.8 million in the same period in 2008. The decrease was primarily due to lower effective interest rates as a result of market conditions as well as a change in the asset allocation of Onyx's investment portfolio.

Interest Expense

Interest expense of $2.3 million for the third quarter 2009 relates to the 4.0% convertible senior notes due 2016 issued in August 2009, and includes non-cash imputed interest expense of $1.0 million as a result of the application of ASC Subtopic 470-20 (formerly known as FSP APB 14-1).

Cash, Cash Equivalents and Marketable Securities

At September 30, 2009, cash, cash equivalents, and current and noncurrent marketable securities were $843.1 million, compared to $458.0 million at December 31, 2008. This increase was primarily due to net proceeds of debt and equity financings in August 2009 and cash generated from operations.

Nine-Month Results

Nexavar net sales, as recorded by Bayer, were $608.3 million and $501.3 million for the nine months ended September 30, 2009 and 2008, respectively. Non-GAAP net income for the nine months ended September 30, 2009 was $45.6 million, or $0.73 per diluted share, compared to non-GAAP net income of $45.9 million, or $0.81 per diluted share for the same period in 2008, excluding employee stock-based compensation expense, non-cash imputed interest expense related to the application of ASC Subtopic 470-20 (formerly known as FSP APB 14-1), acquisition related transaction costs and a payment to BTG International Limited in connection with the achievement of a development milestone in the ONX 0801 program. A description of the non-GAAP calculations is provided below in the accompanying table entitled "Reconciliation of GAAP to Non-GAAP Net Income." For the nine months ended September 30, 2009, on a GAA
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
2. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
3. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
4. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
5. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
6. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
9. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
10. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... on prevention, experts say , , THURSDAY, Dec. 17 ... getting better at treating heart attacks and other ... basic rules for preventing them, according to new ... the list: too little exercise, too much weight. ... last year reported no activity vigorous enough to ...
(Date:12/17/2009)... outbreak is a good time to get vaccinated, federal ... -- As the current wave of H1N1 swine flu ... that everyone get vaccinated in case another outbreak strikes ... H1N1 flu vaccine have eased, it,s an ideal time ... Secretary Kathleen Sebelius said during a morning press conference. ...
(Date:12/17/2009)... Reportlinker.com announces that a new market research ... India Healthcare IT Investment Opportunities, Analysis ... http://www.reportlinker.com/p0169911/India-Healthcare-IT-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html ,, India Healthcare IT Investment ... Summary ,, This report is ... data relating to India healthcare IT market. ...
(Date:12/17/2009)... 17 Today, CDC,s Morbidity and Mortality ... the number of state-level epidemiologists has decreased steadily ... 10% since 2006. There was also a substantial ... period, including epidemiology capacity for bioterrorism and emergency ... such as occupational health, substance abuse, and oral ...
(Date:12/17/2009)... Dec. 17 /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, ... Stock Code: 801) is pleased to announce today ... period under review, the Group,s two,associate companies made ... and NASDAQ;,its key businesses have been strengthened, with ... management operations. , Mr. ...
Breaking Medicine News(10 mins):Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3Health News:Swine Flu Wanes, But Future Uncertain 2Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 2Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 3Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 4Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 5Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 6Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 7Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 8Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3
... New research shows that men who are angry or hostile ... likely to suffer from an irregular // heart rhythm called ... of the heart quiver instead of beating effectively. This can ... for a stroke. Researchers say this is the first study ...
... many inappropriate medications for older people. Using data from ... patterns in physicians’ offices and outpatient clinics in 1995 ... all the visits involved prescribing at least one drug ... visits involved the prescribing of a drug considered by ...
... According to a recent study researchers say the estrogen pills ... lead to an increased risk of stroke.// ,Researchers ... increase or decrease the risk of heart disease as combination ... appear to affect a woman’s risk of developing breast cancer. ...
... Older American population constitute 13 percent of the population ... Researchers say depression is a major risk factor ... intervention programs may help reduce suicidal thoughts in depressed ... the University of Pittsburgh studied nearly 600 elderly patients ...
... suggests drinking extra fluids may do more harm than ... examined results from previous studies to determine if recommending ... Previous data has shown during a respiratory infection, such ... amounts of a specific hormone that conserves water. Thus, ...
... increased risk of developing asthma, report researchers // ,however hormone ... risk. ,The incidence of both asthma and COPD are ... percent of Americans have asthma, and deaths due to COPD ... prevalence of asthma tends to change over time, with boys ...
Other Medicine News:
(Date:12/17/2009)... The Dr. Paul Janssen Award for ... nominations. The $100,000 Award recognizes individuals whose efforts ... of human health. Nomination forms are available ... until February 15, 2010. The Award winner is ... world,s top scientists, which features three new members ...
(Date:12/17/2009)... Fix the Bill ,, WASHINGTON, Dec. 17 ... for a Competitive Pharmaceutical Market (CCPM) will launch ... in select states charging that, during this holiday ... of all to brand pharmaceutical companies" by putting ... urge the President to tell Congress to fix ...
(Date:12/17/2009)... AMSTERDAM, December 17 ,Agendia, a world leader ... Food and Drug Administration (FDA) cleared its MammaPrint ... the only FDA-cleared,breast cancer recurrence test available to ... FDA has issued four clearances for MammaPrint, covering,all ... "This FDA clearance, along with our ...
Breaking Medicine Technology:Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 2Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 3FDA Broadens Clearance for Agendia's MammaPrint(R) 2Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 1Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 2Quest Diagnostics HemoCue Subsidiary to Add U S Hospital Laboratory Connectivity to Its HemoCue 201 DM Point of Care Systems 49601 3A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 1Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 2Tianyin Pharmaceutical Co Inc Set to Join Russell Microcap 28R 29 Index 49595 3
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: